Lower-dose radiation therapy effective and safe for HPV-related head and neck cancer after induction chemotherapy, trial finds

American Society for Radiation Oncology (ASTRO)SCOTTSDALE, Ariz., Feb. 13, 2018 /PRNewswire-USNewswire/ -- Results of the phase II OPTIMA clinical trial indicate that patients with head and neck cancers associated with the human papillomavirus (HPV), including those with advanced nodal disease, can receive substantially lower...

Leave a comment

Your email address will not be published.